Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Immunosuppression-Independent Role of Regulatory T Cells against Hypertension-Driven Renal Dysfunctions.

Fabbiano S, Menacho-Márquez M, Robles-Valero J, Pericacho M, Matesanz-Marín A, García-Macías C, Sevilla MA, Montero MJ, Alarcón B, López-Novoa JM, Martín P, Bustelo XR.

Mol Cell Biol. 2015 Oct;35(20):3528-46. doi: 10.1128/MCB.00518-15. Epub 2015 Aug 3.

2.

CD4+CD25+ regulatory T cells suppress contact hypersensitivity reactions through a CD39, adenosine-dependent mechanism.

Ring S, Oliver SJ, Cronstein BN, Enk AH, Mahnke K.

J Allergy Clin Immunol. 2009 Jun;123(6):1287-96.e2. doi: 10.1016/j.jaci.2009.03.022. Epub 2009 May 8.

PMID:
19427686
3.

Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression.

Borsellino G, Kleinewietfeld M, Di Mitri D, Sternjak A, Diamantini A, Giometto R, Höpner S, Centonze D, Bernardi G, Dell'Acqua ML, Rossini PM, Battistini L, Rötzschke O, Falk K.

Blood. 2007 Aug 15;110(4):1225-32. Epub 2007 Apr 20.

PMID:
17449799
4.

Activated regulatory T-cells attenuate myocardial ischaemia/reperfusion injury through a CD39-dependent mechanism.

Xia N, Jiao J, Tang TT, Lv BJ, Lu YZ, Wang KJ, Zhu ZF, Mao XB, Nie SF, Wang Q, Tu X, Xiao H, Liao YH, Shi GP, Cheng X.

Clin Sci (Lond). 2015 May 1;128(10):679-93. doi: 10.1042/CS20140672.

PMID:
25558978
5.

Adenosine and the adenosine A2A receptor agonist, CGS21680, upregulate CD39 and CD73 expression through E2F-1 and CREB in regulatory T cells isolated from septic mice.

Bao R, Shui X, Hou J, Li J, Deng X, Zhu X, Yang T.

Int J Mol Med. 2016 Sep;38(3):969-75. doi: 10.3892/ijmm.2016.2679. Epub 2016 Jul 14.

PMID:
27430240
6.

Angiotensin II contributes to renal fibrosis independently of Notch pathway activation.

Lavoz C, Rodrigues-Diez R, Benito-Martin A, Rayego-Mateos S, Rodrigues-Diez RR, Alique M, Ortiz A, Mezzano S, Egido J, Ruiz-Ortega M.

PLoS One. 2012;7(7):e40490. doi: 10.1371/journal.pone.0040490. Epub 2012 Jul 9.

7.

CD39+ regulatory T cells attenuate allergic airway inflammation.

Li P, Gao Y, Cao J, Wang W, Chen Y, Zhang G, Robson SC, Wu Y, Yang J.

Clin Exp Allergy. 2015 Jun;45(6):1126-37. doi: 10.1111/cea.12521.

PMID:
25728362
8.

IL-35 stimulation of CD39+ regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10.

Kochetkova I, Golden S, Holderness K, Callis G, Pascual DW.

J Immunol. 2010 Jun 15;184(12):7144-53. doi: 10.4049/jimmunol.0902739. Epub 2010 May 10.

9.

Angiotensin II-induced dilated cardiomyopathy in Balb/c but not C57BL/6J mice.

Peng H, Yang XP, Carretero OA, Nakagawa P, D'Ambrosio M, Leung P, Xu J, Peterson EL, González GE, Harding P, Rhaleb NE.

Exp Physiol. 2011 Aug;96(8):756-64. doi: 10.1113/expphysiol.2011.057612. Epub 2011 May 20.

10.

Regulatory T cells ameliorate angiotensin II-induced cardiac damage.

Kvakan H, Kleinewietfeld M, Qadri F, Park JK, Fischer R, Schwarz I, Rahn HP, Plehm R, Wellner M, Elitok S, Gratze P, Dechend R, Luft FC, Muller DN.

Circulation. 2009 Jun 9;119(22):2904-12. doi: 10.1161/CIRCULATIONAHA.108.832782. Epub 2009 May 26.

PMID:
19470887
11.

IL-2/anti-IL-2 complex attenuates renal ischemia-reperfusion injury through expansion of regulatory T cells.

Kim MG, Koo TY, Yan JJ, Lee E, Han KH, Jeong JC, Ro H, Kim BS, Jo SK, Oh KH, Surh CD, Ahn C, Yang J.

J Am Soc Nephrol. 2013 Oct;24(10):1529-36. doi: 10.1681/ASN.2012080784. Epub 2013 Jul 5.

12.

CD39 is involved in mediating suppression by Mycobacterium bovis BCG-activated human CD8(+) CD39(+) regulatory T cells.

Boer MC, van Meijgaarden KE, Bastid J, Ottenhoff TH, Joosten SA.

Eur J Immunol. 2013 Jul;43(7):1925-32. doi: 10.1002/eji.201243286. Epub 2013 May 29.

13.

Renal Denervation Prevents Immune Cell Activation and Renal Inflammation in Angiotensin II-Induced Hypertension.

Xiao L, Kirabo A, Wu J, Saleh MA, Zhu L, Wang F, Takahashi T, Loperena R, Foss JD, Mernaugh RL, Chen W, Roberts J 2nd, Osborn JW, Itani HA, Harrison DG.

Circ Res. 2015 Aug 28;117(6):547-57. doi: 10.1161/CIRCRESAHA.115.306010. Epub 2015 Jul 8.

14.

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression.

Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, Erat A, Chen JF, Enjyoji K, Linden J, Oukka M, Kuchroo VK, Strom TB, Robson SC.

J Exp Med. 2007 Jun 11;204(6):1257-65. Epub 2007 May 14.

15.

Isolated CD39 expression on CD4+ T cells denotes both regulatory and memory populations.

Zhou Q, Yan J, Putheti P, Wu Y, Sun X, Toxavidis V, Tigges J, Kassam N, Enjyoji K, Robson SC, Strom TB, Gao W.

Am J Transplant. 2009 Oct;9(10):2303-11. doi: 10.1111/j.1600-6143.2009.02777.x. Epub 2009 Jul 28.

16.

The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation.

Rissiek A, Baumann I, Cuapio A, Mautner A, Kolster M, Arck PC, Dodge-Khatami A, Mittrücker HW, Koch-Nolte F, Haag F, Tolosa E.

J Autoimmun. 2015 Apr;58:12-20. doi: 10.1016/j.jaut.2014.12.007. Epub 2015 Jan 29.

PMID:
25640206
17.

Allogeneic effector/memory Th-1 cells impair FoxP3+ regulatory T lymphocytes and synergize with chaperone-rich cell lysate vaccine to treat leukemia.

Janikashvili N, LaCasse CJ, Larmonier C, Trad M, Herrell A, Bustamante S, Bonnotte B, Har-Noy M, Larmonier N, Katsanis E.

Blood. 2011 Feb 3;117(5):1555-64. doi: 10.1182/blood-2010-06-288621. Epub 2010 Dec 1.

18.

Interleukin-6 receptor blockade enhances CD39+ regulatory T cell development in rheumatoid arthritis and in experimental arthritis.

Thiolat A, Semerano L, Pers YM, Biton J, Lemeiter D, Portales P, Quentin J, Jorgensen C, Decker P, Boissier MC, Louis-Plence P, Bessis N.

Arthritis Rheumatol. 2014 Feb;66(2):273-83. doi: 10.1002/art.38246.

19.

CD39 is highly involved in mediating the suppression activity of tumor-infiltrating CD8+ T regulatory lymphocytes.

Parodi A, Battaglia F, Kalli F, Ferrera F, Conteduca G, Tardito S, Stringara S, Ivaldi F, Negrini S, Borgonovo G, Simonato A, Traverso P, Carmignani G, Fenoglio D, Filaci G.

Cancer Immunol Immunother. 2013 May;62(5):851-62. doi: 10.1007/s00262-013-1392-z. Epub 2013 Jan 29.

20.

Essential role of program death 1-ligand 1 in regulatory T-cell-afforded protection against blood-brain barrier damage after stroke.

Li P, Mao L, Liu X, Gan Y, Zheng J, Thomson AW, Gao Y, Chen J, Hu X.

Stroke. 2014 Mar;45(3):857-64. doi: 10.1161/STROKEAHA.113.004100. Epub 2014 Feb 4.

Supplemental Content

Support Center